PTC Therapeutics reports Q4 Sephience revenue of $92.5 million
Go back to PTC Therapeutics reports Q4 Sephience revenue of $92.5 million| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 71.06 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $71.06 | 52 Week High | $35.40 | |||
| Open | $71.06 | 52 Week Low | $4.03 | |||
| Day High | $71.06 | P/E | 7.56 | |||
| Day Low | $71.06 | EPS | $9.40 | |||
| Volume | 460 | |||||
